AMI Asset Management Corp lessened its position in Becton, Dickinson and Company (NYSE:BDX) by 4.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 211,879 shares of the medical instruments supplier’s stock after selling 9,922 shares during the period. Becton, Dickinson and makes up 2.9% of AMI Asset Management Corp’s portfolio, making the stock its 4th largest position. AMI Asset Management Corp owned 0.10% of Becton, Dickinson and worth $41,340,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in BDX. BlackRock Inc. increased its holdings in shares of Becton, Dickinson and by 2,427.8% in the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock worth $3,034,470,000 after acquiring an additional 15,887,611 shares during the period. Vanguard Group Inc. increased its holdings in shares of Becton, Dickinson and by 5.3% in the 1st quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock worth $2,917,094,000 after acquiring an additional 796,034 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Becton, Dickinson and by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock worth $727,863,000 after acquiring an additional 242,081 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Becton, Dickinson and by 1.2% in the 1st quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock worth $602,246,000 after acquiring an additional 39,362 shares during the period. Finally, Fundsmith LLP increased its holdings in shares of Becton, Dickinson and by 3.2% in the 1st quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock worth $421,291,000 after acquiring an additional 71,691 shares during the period. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Becton, Dickinson and Company (NYSE:BDX) traded down 0.15% during trading on Friday, reaching $199.15. 757,084 shares of the company’s stock traded hands. The firm’s 50 day moving average is $200.24 and its 200-day moving average is $190.15. The company has a market capitalization of $45.32 billion, a price-to-earnings ratio of 57.67 and a beta of 1.06. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $206.63.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.44 by $0.02. The business had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.35 EPS. Analysts expect that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.73 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 annualized dividend and a yield of 1.47%. Becton, Dickinson and’s dividend payout ratio is currently 83.43%.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/03/becton-dickinson-and-company-bdx-shares-sold-by-ami-asset-management-corp.html.

A number of analysts recently weighed in on BDX shares. BidaskClub cut shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Bank of America Corporation reaffirmed a “buy” rating and issued a $225.00 price objective (up previously from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Zacks Investment Research cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Finally, Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and dropped their price objective for the stock from $210.00 to $180.00 in a report on Friday, June 30th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $195.79.

In other Becton, Dickinson and news, EVP Ribo Alberto Mas sold 7,463 shares of the business’s stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $201.41, for a total transaction of $1,503,122.83. Following the completion of the sale, the executive vice president now directly owns 29,323 shares of the company’s stock, valued at approximately $5,905,945.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Linda M. Tharby sold 4,695 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $200.48, for a total value of $941,253.60. Following the sale, the executive vice president now directly owns 18,670 shares of the company’s stock, valued at $3,742,961.60. The disclosure for this sale can be found here. Insiders have sold a total of 48,605 shares of company stock valued at $9,718,986 over the last three months. Company insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.